LINC01883

Across TCGA pan-cancer cohorts, LINC01883 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01883’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where LINC01883 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01883 is over-expressed in tumor, although a few such as BRCA and ESCA show the opposite, repressed pattern.

BRCA, LUSC, and ESCA are the cancer types where LINC01883 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01883 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.967	<.001	6	view →
LUSC	All	All	+0.190	.001	4	view →
ESCA	Female	All	−0.346	.037	1	view →
STAD	All	All	−0.075	.041	1	view →
LUAD	All	All	+0.067	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01883–BRCA

Open the BRCA breakdown →